CSL (CSLLY) Beginning Cash Position : $1,509 Mil (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is CSL Beginning Cash Position?

CSL's Beginning Cash Position for the quarter that ended in Dec. 2023 was $1,509 Mil.

CSL's quarterly Beginning Cash Position declined from Dec. 2022 ($10,334 Mil) to Jun. 2023 ($1,457 Mil) but then increased from Jun. 2023 ($1,457 Mil) to Dec. 2023 ($1,509 Mil).

CSL's annual Beginning Cash Position increased from Jun. 2021 ($1,151 Mil) to Jun. 2022 ($1,730 Mil) and increased from Jun. 2022 ($1,730 Mil) to Jun. 2023 ($10,334 Mil).

CSL Beginning Cash Position Historical Data

The historical data trend for CSL's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CSL Beginning Cash Position Chart

CSL Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Beginning Cash Position

Get a 7-Day Free Trial

812.70

657.80

1,151.30

1,730.10

10,334.00

CSL Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Beginning Cash Position	Get a 7-Day Free Trial															1,730.10	6,249.40	10,334.40	1,457.30	1,509.00

CSL Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

CSL Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of CSL's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

CSL (CSLLY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CSL Ltd (OTCPK:CSLLY) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

CMXHF:USA CSJ:Germany CSL:Australia

Address

655 Elizabeth Street, Melbourne, VIC, AUS, 3000

Website

https://www.csl.com

CSL is one of the largest global biotech companies and has two main segments. CSL Behring either uses plasma-derived proteins or recombinants to treat conditions including immunodeficiencies, bleeding disorders and neurological indications. Seqirus is now the world's second largest influenza vaccination business and was acquired in fiscal 2015. CSL has a strong R&D track record, and the product portfolio and pipeline include non-plasma products as the firm continues to broaden its scope. Originally formed in Australia as a government-owned entity, CSL now earns roughly half its revenue in North America and a quarter in Europe.